SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-16-112159
Filing Date
2016-04-18
Accepted
2016-04-18 17:25:46
Documents
5
Effectiveness Date
2016-04-18

Document Format Files

Seq Description Document Type Size
1 DEFA14A a16-2092_3defa14a.htm DEFA14A 33811
2 GRAPHIC g20921cgi001.gif GRAPHIC 69555
3 GRAPHIC g20921cgi002.gif GRAPHIC 103490
4 GRAPHIC g20921cgi003.gif GRAPHIC 46154
5 GRAPHIC g20921cgi004.gif GRAPHIC 34423
  Complete submission text file 0001104659-16-112159.txt   384353
Mailing Address 281 TRESSER BOULEVARD, 9TH FLOOR STAMFORD CT 06901
Business Address 281 TRESSER BOULEVARD, 9TH FLOOR STAMFORD CT 06901 203-653-3880
Loxo Oncology, Inc. (Filer) CIK: 0001581720 (see all company filings)

IRS No.: 462996673 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36562 | Film No.: 161577519
SIC: 2834 Pharmaceutical Preparations